Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
Lancet. 2023 Mar 11;401(10379):843-855. doi: 10.1016/S0140-6736(22)02644-7.
Lancet. 2023.
PMID: 36906345
Clinical Trial.
Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
Buddy Creech C, Jimenez-Truque N, Kown N, Sokolow K, Brady EJ, Yoder S, Solovay K, Rubin K, Noviello S, Hensel E, Selamawi S, Bakare A, Makowski M, Lu K.
Buddy Creech C, et al. Among authors: solovay k.
Vaccine. 2022 Nov 8;40(47):6740-6746. doi: 10.1016/j.vaccine.2022.09.075. Epub 2022 Oct 8.
Vaccine. 2022.
PMID: 36220716
Clinical Trial.
Item in Clipboard
Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.
Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Loré K.
Lin A, et al. Among authors: solovay k.
J Clin Invest. 2020 May 1;130(5):2332-2346. doi: 10.1172/JCI135020.
J Clin Invest. 2020.
PMID: 31945015
Free PMC article.
Clinical Trial.
Item in Clipboard
Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1.
Thalen M, Debrie AS, Coutte L, Raze D, Solovay K, Rubin K, Mielcarek N, Locht C.
Thalen M, et al. Among authors: solovay k.
Vaccines (Basel). 2020 Sep 13;8(3):523. doi: 10.3390/vaccines8030523.
Vaccines (Basel). 2020.
PMID: 32933132
Free PMC article.
Item in Clipboard
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team.
Jahnmatz M, et al. Among authors: solovay k.
Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17.
Lancet Infect Dis. 2020.
PMID: 32687804
Clinical Trial.
Item in Clipboard
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
Locht C, Papin JF, Lecher S, Debrie AS, Thalen M, Solovay K, Rubin K, Mielcarek N.
Locht C, et al. Among authors: solovay k.
J Infect Dis. 2017 Jul 1;216(1):117-124. doi: 10.1093/infdis/jix254.
J Infect Dis. 2017.
PMID: 28535276
Free PMC article.
Item in Clipboard
Cite
Cite